Z57.9Occupational exposure to unspecified risk factor Z57. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z57. 9 became effective on October 1, 2021.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z77.011ICD-10 Code for Contact with and (suspected) exposure to lead- Z77. 011- Codify by AAPC.
Rheumatoid arthritis with rheumatoid factorICD-10 code M05 for Rheumatoid arthritis with rheumatoid factor is a medical classification as listed by WHO under the range - Arthropathies .
Z03. 89 No diagnosis This diagnosis description is CHANGED from “No Diagnosis” to “Encounter for observation for other suspected diseases and conditions ruled out.” established. October 1, 2019, with the 2020 edition of ICD-10-CM.
ICD-10 Codes for Long-term TherapiesCodeLong-term (current) use ofZ79.899other drug therapyH – Not Valid for Claim SubmissionZ79drug therapy21 more rows•Aug 15, 2017
DOM covers CPT code 83655 (lead testing) outside of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) or wellness benefit for all beneficiaries when billed with a QW modifier. The ICD-10 code for contact with and (suspected) exposure to lead is Z77. 011.
9: Fever, unspecified.
The NIOSH Recommended Exposure Limit (REL) for lead is a Time Weighted Average of 50 micrograms per cubic meter of air (µg/m3) over 8-hours. The required (OSHA) Permissible Exposure Limit (PEL) for lead is also no greater than 50 µg/m3 averaged over an 8-hour period.
ICD-10-CM Code for Rheumatoid arthritis, unspecified M06. 9.
ICD-10 code M32. 9 for Systemic lupus erythematosus, unspecified is a medical classification as listed by WHO under the range - Diseases of the musculoskeletal system and connective tissue .
ICD-10 code M19. 90 for Unspecified osteoarthritis, unspecified site is a medical classification as listed by WHO under the range - Arthropathies .
Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective. Most medicines can be dosed correctly without special testing.
ICD-10-CM Codes that Support Medical Necessity For monitoring of patient compliance in a drug treatment program, use diagnosis code Z03. 89 as the primary diagnosis and the specific drug dependence diagnosis as the secondary diagnosis.
Quantitation of detected drugs is not reimbursable. Code 82205 is for therapeutic monitoring only.
01 Long term (current) use of anticoagulants.